Hirakata, Japan

Tomokazu Gotou

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Pharma Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomokazu Gotou. Retrieved from https://idiyas.com/inventor/tomokazu-gotou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tomokazu Gotou: Innovator in Medicinal Chemistry

Introduction

Tomokazu Gotou is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on hydroxamic acid derivatives.

Latest Patents

Tomokazu Gotou holds 1 patent for his invention titled "Hydroxamic acid derivatives and medicinal utilization thereof." This patent showcases his expertise in developing compounds that have potential therapeutic applications.

Career Highlights

Currently, Tomokazu Gotou is employed at Mitsubishi Pharma Corporation, where he continues to advance his research in medicinal chemistry. His work is instrumental in the development of new medicinal products that can improve patient outcomes.

Collaborations

Throughout his career, Tomokazu has collaborated with esteemed colleagues such as Naoki Sugiyama and Kazuhiro Maeda. These partnerships have fostered a collaborative environment that enhances innovation and research productivity.

Conclusion

Tomokazu Gotou's contributions to medicinal chemistry through his patent and work at Mitsubishi Pharma Corporation highlight his role as a key innovator in the field. His ongoing research promises to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…